Irritable bowel syndrome (IBS) is a biopsychosocial disorder that consists of a set of functional disorders that cannot be explained by organic changes in the intestines. At present, it is very important to determine the indicators of quality of life (QOL) in patients with various diseases. QOL analysis allows us to determine how well a patient is coping with the disease, and is also important for addressing many of the issues that arise during treatment. The main complaints of patients were fecal incontinence (100%) and pain syndrome (100%). In patients with IBS with predominance of diarrhea and constipation, the leading symptom in the clinical picture of the disease is pain throughout the bowel, which decreases or disappears after defecation, accompanied by flatulence and a feeling of complete bowel emptying. ± 0.25 points (according to the results of the GSRS survey), which corresponds to severe and moderate intensity pain syndrome. At the end of the course of treatment, a statistically significant decrease in the intensity of abdominal pain was observed in patients.
